Terkko Navigator / British Journal of Haematology

Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents

Current regimens and novel agents for mantle cell lymphoma

Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

Does prolonged storage of red blood cells cause harm?

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis

Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major

Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia

TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells

MDR1 polymorphism influences the outcome of multiple myeloma patients

Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis

Long-term safety of filgrastim (rhG-CSF) administration

Amendments and corrections to the 'Transfusion Guidelines for neonates and older children' (BCSH, 2004a); and to the 'Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant' (BCSH, 2004b)